Ignite Creation Date:
2024-05-05 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262769
Status:
COMPLETED
Last Update Posted:
2012-07-17
First Post:
2005-12-06
Brief Title:
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
Sponsor:
University College London
Organization:
University College London
Organization Data
Organization:
University College London
Class:
OTHER
Study ID:
CDR0000455013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University College London
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |